Keith J Sullivan is President and CEO of Neuronetics, Inc.. Currently has a direct ownership of 1.32 Million shares of STIM, which is worth approximately $1.13 Million. The most recent transaction as insider was on Jul 18, 2024, when has been sold 24,162 shares (Common Stock) at a price of $1.9 per share, resulting in proceeds of $45,907. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.32M
3.49% 3M change
12.46% 12M change
Total Value Held $1.13 Million

Keith J Sullivan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 18 2024
SELL
Open market or private sale
$45,907 $1.9 p/Share
24,162 Reduced 1.79%
1,324,354 Common Stock
Jul 17 2024
SELL
Open market or private sale
$23,023 $1.97 p/Share
11,687 Reduced 0.86%
1,348,516 Common Stock
Jul 16 2024
SELL
Open market or private sale
$23,063 $1.91 p/Share
12,075 Reduced 0.88%
1,360,203 Common Stock
Feb 26 2024
SELL
Open market or private sale
$66,963 $3.3 p/Share
20,292 Reduced 1.46%
1,372,278 Common Stock
Feb 23 2024
SELL
Open market or private sale
$67,022 $3.23 p/Share
20,750 Reduced 1.47%
1,392,570 Common Stock
Feb 22 2024
SELL
Open market or private sale
$67,348 $3.23 p/Share
20,851 Reduced 1.45%
1,413,320 Common Stock
Feb 20 2024
SELL
Open market or private sale
$70,915 $2.96 p/Share
23,958 Reduced 1.64%
1,434,171 Common Stock
Feb 05 2024
BUY
Grant, award, or other acquisition
-
300,000 Added 17.06%
1,458,129 Common Stock
Jan 11 2024
SELL
Open market or private sale
$30,070 $3.16 p/Share
9,516 Reduced 0.81%
1,158,129 Common Stock
Jan 10 2024
SELL
Open market or private sale
$30,139 $3.01 p/Share
10,013 Reduced 0.85%
1,167,645 Common Stock
Jul 21 2023
SELL
Open market or private sale
$13,364 $2.04 p/Share
6,551 Reduced 0.55%
1,177,658 Common Stock
Jul 20 2023
SELL
Open market or private sale
$13,410 $2.06 p/Share
6,510 Reduced 0.55%
1,184,209 Common Stock
Jul 19 2023
SELL
Open market or private sale
$13,411 $2.07 p/Share
6,479 Reduced 0.54%
1,190,719 Common Stock
Feb 14 2023
SELL
Open market or private sale
$76,150 $5.58 p/Share
13,647 Reduced 1.13%
1,197,198 Common Stock
Feb 13 2023
SELL
Open market or private sale
$138,095 $5.49 p/Share
25,154 Reduced 2.04%
1,210,845 Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
285,000 Added 18.74%
1,235,999 Common Stock
Oct 20 2022
BUY
Exercise of conversion of derivative security
$198,000 $1.98 p/Share
100,000 Added 9.51%
950,999 Common Stock
Jul 18 2022
SELL
Open market or private sale
$236,094 $3.72 p/Share
63,466 Reduced 6.94%
850,999 Common Stock
Feb 09 2022
BUY
Grant, award, or other acquisition
-
283,912 Added 23.69%
914,465 Common Stock
Jul 16 2021
SELL
Open market or private sale
$1,269 $13.64 p/Share
93 Reduced 0.01%
630,553 Common Stock
Jul 15 2021
SELL
Open market or private sale
$685,020 $13.46 p/Share
50,893 Reduced 7.47%
630,646 Common Stock
Feb 05 2021
SELL
Open market or private sale
$819,551 $17.96 p/Share
45,632 Reduced 6.28%
681,539 Common Stock
Feb 01 2021
BUY
Grant, award, or other acquisition
-
125,000 Added 14.67%
727,171 Common Stock
Jan 26 2021
SELL
Open market or private sale
$429,870 $18.83 p/Share
22,829 Reduced 3.65%
602,171 Common Stock
Jan 12 2021
BUY
Grant, award, or other acquisition
-
125,000 Added 16.67%
625,000 Common Stock

Also insider at

CUTR
CUTERA INC Healthcare
SIEN
Sientra, Inc. Healthcare
VERO
Venus Concept Inc. Healthcare
KJS

Keith J Sullivan

President and CEO
Malvern, PA

Track Institutional and Insider Activities on STIM

Follow Neuronetics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STIM shares.

Notify only if

Insider Trading

Get notified when an Neuronetics, Inc. insider buys or sells STIM shares.

Notify only if

News

Receive news related to Neuronetics, Inc.

Track Activities on STIM